Skip to main navigation Skip to search Skip to main content

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

  • Van K. Morris
  • , Mohamed E. Salem
  • , Halla Nimeiri
  • , Syma Iqbal
  • , Preet Singh
  • , Kristen Ciombor
  • , Blase Polite
  • , Dustin Deming
  • , Emily Chan
  • , James L. Wade
  • , Lianchun Xiao
  • , Tanios Bekaii-Saab
  • , Luis Vence
  • , Jorge Blando
  • , Armeen Mahvash
  • , Wai Chin Foo
  • , Chimela Ohaji
  • , Manolo Pasia
  • , Gail Bland
  • , Aki Ohinata
    • Jane Rogers, Amir Mehdizadeh, Kimberly Banks, Richard Lanman, Robert A. Wolff, Howard Streicher, James Allison, Padmanee Sharma, Cathy Eng

Research output: Contribution to journal › Article › peer-review

382   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry